243 related articles for article (PubMed ID: 30098913)
1. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y
Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913
[TBL] [Abstract][Full Text] [Related]
2. Liposomes actively recognizing the glucose transporter GLUT
Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
[TBL] [Abstract][Full Text] [Related]
3. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
4. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
[TBL] [Abstract][Full Text] [Related]
5. Ascorbic acid-modified brain-specific liposomes drug delivery system with "lock-in" function.
Xiao W; Fu Q; Zhao Y; Zhang L; Yue Q; Hai L; Guo L; Wu Y
Chem Phys Lipids; 2019 Nov; 224():104727. PubMed ID: 30660746
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Yang Y; Zhao Z; Xie C; Zhao Y
Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting.
Zhao Z; Chen C; Xie C; Zhao Y
Chem Phys Lipids; 2020 Jan; 226():104832. PubMed ID: 31560875
[TBL] [Abstract][Full Text] [Related]
8. Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery.
Huang M; Pu Y; Peng Y; Fu Q; Guo L; Wu Y; Zheng Y
Bioorg Med Chem Lett; 2020 Jun; 30(12):127151. PubMed ID: 32317211
[TBL] [Abstract][Full Text] [Related]
9. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
10. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeting liposomes with active recognition of GLUT
Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation for docetaxel-loaded brain targeting liposome with "lock-in" function.
Li X; Qu B; Jin X; Hai L; Wu Y
J Drug Target; 2014 Oct; 22(3):251-261. PubMed ID: 24313929
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
[TBL] [Abstract][Full Text] [Related]
15. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
[TBL] [Abstract][Full Text] [Related]
16. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
[TBL] [Abstract][Full Text] [Related]
17. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.
Xie F; Yao N; Qin Y; Zhang Q; Chen H; Yuan M; Tang J; Li X; Fan W; Zhang Q; Wu Y; Hai L; He Q
Int J Nanomedicine; 2012; 7():163-75. PubMed ID: 22275832
[TBL] [Abstract][Full Text] [Related]
18. Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency.
Li Z; Lu J; Tang B; Shi Y; Hai L; Guo L; Wu Y
Bioorg Med Chem; 2022 Apr; 60():116704. PubMed ID: 35286953
[TBL] [Abstract][Full Text] [Related]
19. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of a chitosan-coated antioxidant liposome containing vitamin C and folic acid.
Jiao Z; Wang X; Yin Y; Xia J; Mei Y
J Microencapsul; 2018 May; 35(3):272-280. PubMed ID: 29671362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]